David Veitch
Chief Executive Officer at BASILEA PHARMACEUTICA AG
Net worth: 54 341 $ as of 2024-03-30
David Veitch active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BASILEA PHARMACEUTICA AG | Chief Executive Officer | 2018-04-18 | - |
| Corporate Officer/Principal | 2014-08-31 | 2018-04-18 |
Career history of David Veitch
Former positions of David Veitch
| Companies | Position | Start | End |
|---|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 2011-12-31 | 2012-12-31 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | 2003-12-31 | 2010-12-31 |
Training of David Veitch
| University of Bristol | Undergraduate Degree |
Statistics
International
| United Kingdom | 3 |
| United States | 2 |
| Switzerland | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BASILEA PHARMACEUTICA AG | Health Technology |
| Private companies | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
- Stock Market
- Insiders
- David Veitch
- Experience
